Related Experiment Video
Updated: Dec 23, 2025

06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
10.2K
Returning to work after head and neck cancer.
Abi Miller1,2
1University of Nottingham, Nottingham.
Current Opinion in Otolaryngology & Head and Neck Surgery
|April 30, 2020
Summary
Return to work after head and neck cancer (HNC) treatment is understudied. Survivors face complex challenges, necessitating further research for effective workplace interventions.
Area of Science:
- Oncology
- Occupational Health
- Rehabilitation Medicine
Background:
- Head and neck cancer (HNC) survival rates have improved, increasing the number of working-age survivors.
- There's a rising incidence of HNC, particularly oral and pharyngeal types, in younger populations (under 65).
- This demographic shift, linked to human papilloma virus (HPV), creates a growing need to understand survivorship issues like return to work (RTW).
Purpose of the Study:
- To review the current evidence on return to work (RTW) for head and neck cancer (HNC) survivors.
- To identify gaps in knowledge regarding the challenges and experiences of HNC survivors in the workplace.
- To highlight the need for developing targeted interventions to support RTW for this population.
Main Methods:
- Systematic literature review of studies on RTW in head and neck cancer patients.
- Analysis of factors influencing RTW and work-related experiences.
- Identification of research gaps and areas for future investigation.
Main Results:
- Evidence suggests HNC survivors return to work at lower rates compared to survivors of other cancers.
- The existing knowledge base on RTW after HNC is limited and conclusions are difficult to draw.
- There is a scarcity of research focusing on the lived experiences of HNC survivors regarding their return to work.
Conclusions:
- There is an urgent need for comprehensive research into the needs and concerns of HNC survivors returning to work.
- Further exploration of survivor perspectives is crucial for understanding RTW barriers.
- The ultimate goal is to develop evidence-based interventions to facilitate successful RTW and sustained employment for HNC survivors.
Related Concept Videos
Classification of Illness
8.4K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.4K
Veins of Head and Neck
4.8K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
4.8K
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Survival Analysis
584
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
584
Restorative Care
2.2K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.2K
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K

